Ireland's Elan invests in Ethical's rescue
This article was originally published in Clinica
Executive Summary
The Irish drug delivery company, Elan, is to invest $16 million in refinancing Ethical Pharmaceuticals, a UK company which has proprietary oral and transdermal drug delivery technologies.